FRAXIPARINE 5700 IU AXa/0.6 ML

Nazione: Israele

Lingua: inglese

Fonte: Ministry of Health

Principio attivo:

NADROPARIN CALCIUM 5700 IU / 0.6 ML

Commercializzato da:

GLAXO SMITH KLINE (ISRAEL) LTD

Codice ATC:

B01AB06

Forma farmaceutica:

SOLUTION FOR INJECTION

Via di somministrazione:

S.C

Prodotto da:

GLAXO WELLCOME PRODUCTION, FRANCE

Gruppo terapeutico:

NADROPARIN

Indicazioni terapeutiche:

Prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. Treatment of constituted deep vein thrombosis. Prevention of coagulation in the extra corporeal circuit during haemodialysis. The prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.

Data dell'autorizzazione:

2010-07-01